BOOK REVIEWS 567 Prenatal Diagnosis and Selective Abortion

Total Page:16

File Type:pdf, Size:1020Kb

BOOK REVIEWS 567 Prenatal Diagnosis and Selective Abortion BOOK REVIEWS 567 Prenatal Diagnosis and Selective Abortion. By H. HARRIS. London: Nuffield Provincial Hospitals Trust, 1974. Pp. 101. 11.75. U.S. publisher, Harvard University Press. The recent introduction of prenatal detection of genetic disorders has raised a variety of ethical and biological questions. This book not only reviews a number of problems with intrauterine diagnosis, including the scope of the procedure and its effects on the incidence of genetic diseases, but it also raises a number of ethical questions which have generated considerable discussion in both professional and nonprofessional fields. The text is authored by an acknowledged expert in the field of human genetics. Harris has divided his thesis into three major chapters. The first presents an overview of the present state of knowledge of intrauterine diagnosis as it relates to chromosomal abnor- malities, X-linked disorders, metabolic diseases, and congenital malformations. This section does not contain an extensive review of the literature but does highlight many of the more important aspects. The second section deals with effects on the incidence of genetic disease. It outlines both the potential short- and long-term effects that are expected to follow from selective abortion whether the abnormality is a single gene or classical Mendelian condition, a gross chromosomal defect, or a disorder regarded as multifactorial in origin. The last section, which is the most interesting in my opinion, deals with the question of ethics. Harris not only clearly points out the ethical and moral questions of selective abortion, including the undesirable aspects, but he also describes the visible benefits which, in his opinion, make intrauterine detection a valuable advance in medicine. The book is well written, easy to read, and reflects Harris's wide experience in the field of human genetics. The second and third chapters are especially clear, and the argu- ments presented are easily followed. While little in the book can be considered new or original, since many of the comments and observations have been discussed in numerous recent reviews, the style and clarity should make this book a valuable contribution to the field. The book should form a good introduction to the scope and problems of antenatal diagnosis for students in biology, genetics, and ethics. HENRY L. NADLER Children's Memorial Hospital Chicago, Illinois Heritable Disorders of Amino Acid Metabolism: Patterns of Clinical Expression and Genetic Variation. Edited by W. L. NYHAN. New York: John Wiley & Sons, 1974. Pp. 765. $39.00. This 765-page textbook represents the latest of several recently published texts con- cerned with methods of diagnosis, treatment, and biochemical insight into human meta- bolic pathways offered by studies of the inborn errors of aminoacid metabolism (cf. Duncan's Diseases of Metabolism edited by P. K. Bondy and L. E. Rosenberg, 7th ed., 1974; The Metabolic Basis of Inherited Disease edited by J. B. Stanbury, J. B. Wyn- gaarden, and D. S. Fredrickson, 3d ed., 1972; Amino Acid Metabolism and Its Disorders by C. R. Scriver and L. E. Rosenberg, 1973; and Laboratory Techniques for the Detec- tion of Hereditary Metabolic Disorders by V. E. Shih, 1973). The book contains 33 568 BOOK REVIEWS chapters from 38 contributors. It is subdivided into 11 parts: an introduction by Nyhan; disorders of branched chain amino and organic acid metabolic pathways; phenylketonuria, tyrosinemia, and albinism; histidinemia and carnosinemia; glycinemia and prolinemia; urea cycle defects and lysinemia; sulfur-containing aminoacidopathies; pyroglutamic acidemia; transport defects; nutrition and growth; and methods for screening and investi- gating inborn errors of aminoacid metabolism. The choice of authors for these sections reflects a clear emphasis on practical clinical diagnosis and care. They are pediatricians or clinical biochemists whose practical experience lends an authoritativeness to each chapter. Because newborn screening for inborn errors of metabolism is now mandated in most states, and with the advent of gas chromatography linked with mass spectrometry, this new group of individually rare but collectively important disorders demands broader participation by the community of health care professionals. This text provides a practi- cal resource for these individuals. It has detailed clinical descriptions of patients affected by disorders of aminoacid metabolism, including quantitative values for specific metabo- lites contained in normal and abnormal physiologic fluids. Most chapters are arranged like a traditional clinical textbook with a brief historical review of the given disorder, a description of the phenotype, a discussion of the biochemical pathways involved, a statement of the pathology where indicated, and a description of diagnostic methods including enzyme assays of various tissues. Perhaps the most unique aspect is the inclu- sion of detailed descriptions of diets and therapy where applicable. Many chapters contain specific tables listing model diets with specific aminoacids, lipids, carbohydrates, minerals, and vitamins in table form. The less common disorders which as yet are not clearly defined with respect to diagnosis, mechanism, or treatment are not neglected. There is an excellent review of uncommon disorders of sulfur aminoacid metabolism by J. C. Crawhall and of pyroglutamic acidemia by L. Eldjarn and colleagues. The chapter on aminoacid transport in kidney by C. R. Scriver and M. Bergeron represents a scholarly culmination of several chapters on this subject by these authors which have appeared previously. A chapter by S. Synderman on aminoacid requirements in the infant and that by L. Schmidt on biochemical detection of metabolic disease place the finishing touches on this practical textbook. A few criticisms can be brought to bear, however. The authoritative emphasis on clinical aspects of disease expression, pathogenesis, and treatment produces an optimistic aura of completeness which is not yet warranted. This aura may beguile the reader who is not intimately involved in this field into believing that the facts are all available. Thus, the tabulation of a defect in leucine-isoleucine transamination or the statement that defec- tive electron transfer systems produce sarcosinemia when sarcosine dehydrogenase assays are normal are neither supported by objective evidence or followed by statements of healthy skepticism. The emphasis on diagnosis of metabolic disorders through detection of accumulated precursors in blocked metabolic pathways tends to distract the reader from concern over the primary genetic defect-the proteins (enzymes) involved in these blocked metabolic pathways. Such an emphasis does not lend itself to future research and treatment such as enzyme replacement and genetic engineering. The chapter on homo- cystinuria by T. L. Perry followed by a discussion of selected aspects of enzymes and metabolism related to homocystine metabolism by S. H. Mudd represents a good com- promise between clinical and investigative interests and an example which, if followed in other sections, would have supported the overall textbook. In summary, this book pro- BOOK REVIEWS 569 vides a timely compilation for the diagnosis and treatment of inborn errors of aminoacid metabolism and deserves a place on the shelf with the previous texts on this subject. Louis J. ELSAS, II Emory University Atlanta Georgia The Genetic Structure of Populations. By A. JACQUARD. Translated by D. and B. CHARLESWORTH. Biomathematics, vol. 5. New York: Springer-Verlag, 1974. Pp. 569. $39.40. This book is an English translation of Jacquard's earlier French work Structures genetiques des populations, but it includes a number of new chapters and sections. It is concerned mainly with mathematical theories of population genetics with emphasis on man, though in the last chapter some data analyses are presented. The main topics dis- cussed are random mating populations, inbreeding and assortative mating, some quantita- tive genetics, natural selection, migration, and genetic distance. There are appendixes on difference equations and matrix algebra. Compared with Crow and Kimura's book on the same subject, An Introduction to Population Genetics Theory, the material covered is not so wide ranging. But some topics such as overlapping generations and genetic distance are discussed more extensively than in any other current book. The mathematics used is not very sophisticated. Nearly half of this book is devoted to the theory of inbreeding. Jacquard's treatment of this subject differs somewhat from that of most other textbooks and includes a great deal of mathematical detail and formality. In order to explain the effect of inbreeding he introduces three different concepts of genetic structure which are not really required: genotypic structure, genotypic probability structure, and probability structure of an individual. In the study of relatedness of individuals he considers 15 different types of gene identity between two individuals, which are later condensed into nine cases. The explanation of these identity measures is clear, but because of the recognition of so many different cases, his treatment of this subject becomes very complicated. If we note that Cotterman's k statistics (three cases) are sufficient for most practical purposes, I wonder whether it is worth the extensive discussion. Jacquard also devotes considerable space to a study of the frequencies of consanguine- ous marriages expected under
Recommended publications
  • Inherited Metabolic Disease
    Inherited metabolic disease Dr Neil W Hopper SRH Areas for discussion • Introduction to IEMs • Presentation • Initial treatment and investigation of IEMs • Hypoglycaemia • Hyperammonaemia • Other presentations • Management of intercurrent illness • Chronic management Inherited Metabolic Diseases • Result from a block to an essential pathway in the body's metabolism. • Huge number of conditions • All rare – very rare (except for one – 1:500) • Presentation can be non-specific so index of suspicion important • Mostly AR inheritance – ask about consanguinity Incidence (W. Midlands) • Amino acid disorders (excluding phenylketonuria) — 18.7 per 100,000 • Phenylketonuria — 8.1 per 100,000 • Organic acidemias — 12.6 per 100,000 • Urea cycle diseases — 4.5 per 100,000 • Glycogen storage diseases — 6.8 per 100,000 • Lysosomal storage diseases — 19.3 per 100,000 • Peroxisomal disorders — 7.4 per 100,000 • Mitochondrial diseases — 20.3 per 100,000 Pathophysiological classification • Disorders that result in toxic accumulation – Disorders of protein metabolism (eg, amino acidopathies, organic acidopathies, urea cycle defects) – Disorders of carbohydrate intolerance – Lysosomal storage disorders • Disorders of energy production, utilization – Fatty acid oxidation defects – Disorders of carbohydrate utilization, production (ie, glycogen storage disorders, disorders of gluconeogenesis and glycogenolysis) – Mitochondrial disorders – Peroxisomal disorders IMD presentations • ? IMD presentations • Screening – MCAD, PKU • Progressive unexplained neonatal
    [Show full text]
  • Genes Investigated
    BabyNEXTTM EXTENDED Investigated genes and associated diseases Gene Disease OMIM OMIM Condition RUSP gene Disease ABCC8 Familial hyperinsulinism 600509 256450 Metabolic disorder - ABCC8-related Inborn error of amino acid metabolism ABCD1 Adrenoleukodystrophy 300371 300100 Miscellaneous RUSP multisystem (C) * diseases ABCD4 Methylmalonic aciduria and 603214 614857 Metabolic disorder - homocystinuria, cblJ type Inborn error of amino acid metabolism ACAD8 Isobutyryl-CoA 604773 611283 Metabolic Disorder - RUSP dehydrogenase deficiency Inborn error of (S) ** organic acid metabolism ACAD9 acyl-CoA dehydrogenase-9 611103 611126 Metabolic Disorder - (ACAD9) deficiency Inborn error of fatty acid metabolism ACADM Acyl-CoA dehydrogenase, 607008 201450 Metabolic Disorder - RUSP medium chain, deficiency of Inborn error of fatty (C) acid metabolism ACADS Acyl-CoA dehydrogenase, 606885 201470 Metabolic Disorder - RUSP short-chain, deficiency of Inborn error of fatty (S) acid metabolism ACADSB 2-methylbutyrylglycinuria 600301 610006 Metabolic Disorder - RUSP Inborn error of (S) organic acid metabolism ACADVL very long-chain acyl-CoA 609575 201475 Metabolic Disorder - RUSP dehydrogenase deficiency Inborn error of fatty (C) acid metabolism ACAT1 Alpha-methylacetoacetic 607809 203750 Metabolic Disorder - RUSP aciduria Inborn error of (C) organic acid metabolism ACSF3 Combined malonic and 614245 614265 Metabolic Disorder - methylmalonic aciduria Inborn error of organic acid metabolism 1 ADA Severe combined 608958 102700 Primary RUSP immunodeficiency due
    [Show full text]
  • Amino Acid Disorders
    471 Review Article on Inborn Errors of Metabolism Page 1 of 10 Amino acid disorders Ermal Aliu1, Shibani Kanungo2, Georgianne L. Arnold1 1Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; 2Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA Contributions: (I) Conception and design: S Kanungo, GL Arnold; (II) Administrative support: S Kanungo; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: E Aliu, GL Arnold; (V) Data analysis and interpretation: None; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Georgianne L. Arnold, MD. UPMC Children’s Hospital of Pittsburgh, 4401 Penn Avenue, Suite 1200, Pittsburgh, PA 15224, USA. Email: [email protected]. Abstract: Amino acids serve as key building blocks and as an energy source for cell repair, survival, regeneration and growth. Each amino acid has an amino group, a carboxylic acid, and a unique carbon structure. Human utilize 21 different amino acids; most of these can be synthesized endogenously, but 9 are “essential” in that they must be ingested in the diet. In addition to their role as building blocks of protein, amino acids are key energy source (ketogenic, glucogenic or both), are building blocks of Kreb’s (aka TCA) cycle intermediates and other metabolites, and recycled as needed. A metabolic defect in the metabolism of tyrosine (homogentisic acid oxidase deficiency) historically defined Archibald Garrod as key architect in linking biochemistry, genetics and medicine and creation of the term ‘Inborn Error of Metabolism’ (IEM). The key concept of a single gene defect leading to a single enzyme dysfunction, leading to “intoxication” with a precursor in the metabolic pathway was vital to linking genetics and metabolic disorders and developing screening and treatment approaches as described in other chapters in this issue.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0281166 A1 BHATTACHARJEE Et Al
    US 20160281 166A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0281166 A1 BHATTACHARJEE et al. (43) Pub. Date: Sep. 29, 2016 (54) METHODS AND SYSTEMIS FOR SCREENING Publication Classification DISEASES IN SUBJECTS (51) Int. Cl. (71) Applicant: PARABASE GENOMICS, INC., CI2O I/68 (2006.01) Boston, MA (US) C40B 30/02 (2006.01) (72) Inventors: Arindam BHATTACHARJEE, G06F 9/22 (2006.01) Andover, MA (US); Tanya (52) U.S. Cl. SOKOLSKY, Cambridge, MA (US); CPC ............. CI2O 1/6883 (2013.01); G06F 19/22 Edwin NAYLOR, Mt. Pleasant, SC (2013.01); C40B 30/02 (2013.01); C12O (US); Richard B. PARAD, Newton, 2600/156 (2013.01); C12O 2600/158 MA (US); Evan MAUCELI, (2013.01) Roslindale, MA (US) (21) Appl. No.: 15/078,579 (57) ABSTRACT (22) Filed: Mar. 23, 2016 Related U.S. Application Data The present disclosure provides systems, devices, and meth (60) Provisional application No. 62/136,836, filed on Mar. ods for a fast-turnaround, minimally invasive, and/or cost 23, 2015, provisional application No. 62/137,745, effective assay for Screening diseases, such as genetic dis filed on Mar. 24, 2015. orders and/or pathogens, in Subjects. Patent Application Publication Sep. 29, 2016 Sheet 1 of 23 US 2016/0281166 A1 SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSS S{}}\\93? sau36 Patent Application Publication Sep. 29, 2016 Sheet 2 of 23 US 2016/0281166 A1 &**** ? ???zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz??º & %&&zzzzzzzzzzzzzzzzzzzzzzz &Sssssssssssssssssssssssssssssssssssssssssssssssssssssssss & s s sS ------------------------------ Patent Application Publication Sep. 29, 2016 Sheet 3 of 23 US 2016/0281166 A1 23 25 20 FG, 2. Patent Application Publication Sep. 29, 2016 Sheet 4 of 23 US 2016/0281166 A1 : S Patent Application Publication Sep.
    [Show full text]
  • Amino Acids & Proteins
    Amino Acids & Proteins Amino Acids Amino acids are organic compounds containing both amino group & carboxyl group, those occurring in human proteins are L α-amino acids having the formula RCH(NH2)COOH & with the exception of glycine all amino acids are asymmetric . D-Amino acids that occur naturally are free D-serine& D- aspartate which present in the in brain tissue. Classification of Amino acids Over 300 amino acids occur naturally, however; only 20 of them share in the formation of proteins. Classification of amino acids either according to their R-group or to their nutritional importance. 1-Classification according to R-group(side chain). 1 2 2-Classification according to their nutritional importance All 20 amino acids present in proteins are biologically essential but not all of them are nutritionally essential, therefore, they are classified into: 3 A-Nutritionally essential amino acids :they should be supplement in diet because human body can not synthesize it , there deficiencies lead to kwashiorkor (protein malnutrition) & marasmus (protein & energy malnutrition). B-Nutritionally nonessential amino acids : human body can synthesize it , therefore , it’s not essential to be supplied in the diet. R-group It determines the property of amino acid in peptide formation as: 1-Since glycine is smallest amino acid, therefore, it can accommodate in places inaccessible to other amino acids in the formation of peptide. 4 2-Hydrophobic R-group of alanine, valine, leucine, Isoleucine, & aromatic R-groups of phenylalanine , tyrosine & tryptophan make them in the interior of protein. 3-The charged R-group of basic & acidic amino acids stabilize protein conformation through ionic interaction or salt-bridge.
    [Show full text]
  • Annual Symposium of the Society for the Study of Inborn Errors of Metabolism Birmingham, UK, 4 – 7 September 2012
    J Inherit Metab Dis (2012) 35 (Suppl 1):S1–S182 DOI 10.1007/s10545-012-9512-z ABSTRACTS Annual Symposium of the Society for the Study of Inborn Errors of Metabolism Birmingham, UK, 4 – 7 September 2012 This supplement was not sponsored by outside commercial interests. It was funded entirely by the SSIEM. 01. Amino Acids and PKU O-002 NATURAL INHIBITORS OF CARNOSINASE (CN1) O-001 Peters V1 ,AdelmannK2 ,YardB2 , Klingbeil K1 ,SchmittCP1 , Zschocke J3 3-HYDROXYISOBUTYRIC ACID DEHYDROGENASE DEFICIENCY: 1Zentrum für Kinder- und Jugendmedizin de, Heidelberg, Germany IDENTIFICATION OF A NEW INBORN ERROR OF VALINE 2Universitätsklinik, Mannheim, Germany METABOLISM 3Humangenetik, Innsbruck, Austria Wanders RJA1 , Ruiter JPN1 , Loupatty F.1 , Ferdinandusse S.1 , Waterham HR1 , Pasquini E.1 Background: Carnosinase degrades histidine-containing dipeptides 1Div Metab Dis, Univ Child Hosp, Amsterdam, Netherlands such as carnosine and anserine which are known to have several protective functions, especially as antioxidant agents. We recently Background, Objectives: Until now only few patients with an established showed that low carnosinase activities protect from diabetic nephrop- defect in the valine degradation pathway have been identified. Known athy, probably due to higher histidine-dipeptide concentrations. We deficiencies include 3-hydroxyisobutyryl-CoA hydrolase deficiency and now characterized the carnosinase metabolism in children and identi- methylmalonic semialdehyde dehydrogenase (MMSADH) deficiency. On fied natural inhibitors of carnosinase. the other hand many patients with 3-hydroxyisobutyric aciduria have been Results: Whereas serum carnosinase activity and protein concentrations described with a presumed defect in the valine degradation pathway. To correlate in adults, children have lower carnosinase activity although pro- identify the enzymatic and molecular defect in a group of patients with 3- tein concentrations were within the same level as for adults.
    [Show full text]
  • Omics Knowledgebase for Mammalian Cellular Signaling Pathways
    bioRxiv preprint doi: https://doi.org/10.1101/401729; this version posted August 27, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The Signaling Pathways Project: an integrated ‘omics knowledgebase for mammalian cellular signaling pathways Scott Ochsner, David Abraham*, Kirt Martin*, Wei Ding, Apollo McOwiti, Zichen Wang, Kaitlyn Andreano, Ross A. Hamilton, Yue Chen, Angelica Hamilton, Marin L. Gantner, Michael Dehart, Shijing Qu, Susan G. Hilsenbeck, Lauren B. Becnel, Dave Bridges, Avi Ma’ayan, Janice M. Huss, Fabio Stossi, Charles E. Foulds, Anastasia Kralli, Donald P. McDonnell and Neil J. McKenna Address Correspondence To: Neil J. McKenna Department of Molecular and Cellular Biology Baylor College of Medicine Houston, TX 77030 USA e: [email protected] t: 713-798-8568 *These authors contributed equally to this study 1 bioRxiv preprint doi: https://doi.org/10.1101/401729; this version posted August 27, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Summary Public transcriptomic and ChIP-Seq datasets have the potential to illuminate facets of transcriptional regulation by mammalian cellular signaling pathways not yet explored in the research literature. Unfortunately, a variety of obstacles prevent routine re-use of these datasets by bench biologists for hypothesis generation and data validation. Here, we designed a web knowledgebase, the Signaling Pathways Project (SPP), which incorporates stable community classifications of three major categories of cellular signaling pathway node (receptors, enzymes and transcription factors) and the bioactive small molecules (BSMs) known to modulate their functions.
    [Show full text]
  • Amino Acid Disorders Detected by Quantitative Amino Acid HPLC Analysis in Thailand: an Eight-Year Experience
    ارا ه ت ه از $&% #ت "! Clinica Chimica Acta 413 (2012) 1141–1144 Contents lists available at SciVerse ScienceDirect Clinica Chimica Acta journal homepage: www.elsevier.com/locate/clinchim Amino acid disorders detected by quantitative amino acid HPLC analysis in Thailand: An eight-year experience Nithiwat Vatanavicharn ⁎, Pisanu Ratanarak, Somporn Liammongkolkul, Achara Sathienkijkanchai, Pornswan Wasant Division of Medical Genetics, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand article info abstract Article history: Background: Amino acid disorders are a major group of inborn errors of metabolism (IEM) with variable clin- Received 13 October 2011 ical presentations. This study was aimed to provide the data of amino acid disorders detected in high-risk Received in revised form 16 March 2012 Thai patients referred to our metabolic lab from all over the country. Accepted 20 March 2012 Methods: From 2001 to 2009, we analyzed amino acids by HPLC in 1214 plasma and cerebrospinal fluid spec- Available online 23 March 2012 imens. These specimens were obtained from patients with clinical suspicion of IEM or with positive newborn screening. The clinical data of the patients with confirmed diagnoses of amino acid disorders were also ana- Keywords: lyzed. Amino acid disorders HPLC Results: Fifty-eight patients were diagnosed with amino acid disorders, including 20 cases (34.5%) with maple Thailand syrup urine disease, 13 (22.4%) with phenylketonuria and hyperphenylalaninemia, 13 (22.4%) with nonke- totic hyperglycinemia, 9 (15.5%) with urea cycle defects, 2 (3.4%) with classical homocystinuria, and 1 (1.7%) with ornithine aminotransferase deficiency. There was considerable delay in diagnoses which led to poor outcomes in most patients.
    [Show full text]
  • Enteral Nutrition
    UnitedHealthcare® Commercial Coverage Determination Guideline Enteral Nutrition Guideline Number: CDG.027.03 Effective Date: July 1, 2021 Instructions for Use Table of Contents Page Related Commercial Policies Coverage Rationale ........................................................................... 1 • Durable Medical Equipment, Orthotics, Medical Definitions ........................................................................................... 2 Supplies and Repairs/ Replacements Applicable Codes .............................................................................. 3 References .......................................................................................10 Community Plan Policy Guideline History/Revision Information .......................................10 • Oral and Enteral Nutrition Instructions for Use .........................................................................10 Coverage Rationale Indications for Coverage Certain plans may include coverage for enteral nutrition (enteral formulas and low protein modified food products). Refer to the member specific benefit plan document to determine if this coverage applies. For Plans with Language that Cover Enteral Nutrition For plans that cover enteral nutrition, if there is a difference between a member specific benefit plan document and the information below, the member specific benefit plan document should be used for making benefit determinations. Note: Check state mandate applicability before proceeding with the following. Benefits are provided
    [Show full text]
  • Catabolism of the Carbon Skeletons of Amino Acids
    Bio. 2. ASPU. Lectu.3. Prof. Dr. F. ALQuobaili Catabolism of the Carbon Skeletons of Amino Acids • Biomedical Importance ‐ The metabolic diseases or "inborn errors of metabolism" associated with conversion of the carbon skeletons of the common L ‐‐amino acids to amphibolic intermediates can result in irreversible brain damage and .(ﺍﻟﻭﻓﺎﺓ) early mortality ‐ Prenatal or early postnatal detection and timely initiation of treatment thus are essential. Almost all states conduct screening tests for up to as many as 30 metabolic diseases. ‐ The best screening tests use tandem mass spectrometry to detect, in a few drops of neonate blood, catabolites suggestive of a metabolic defect. ‐ Treatment consists primarily of feeding diets low in the amino acids whose catabolism is impaired. • Transamination Typically Initiates Amino Acid Catabolism Removal of ‐amino nitrogen by transamination is the first catabolic reaction of amino acids except for proline, hydroxyproline, threonine, and lysine. The hydrocarbon skeleton that remains is then degraded to amphibolic intermediates. • Asparagine, Aspartate, Glutamine, and Glutamate All four carbons of asparagine and aspartate form oxaloacetate. Analogous reactions convert glutamine and glutamate to ‐ ketoglutarate. No metabolic defects are associated with the catabolism of these four amino acids. • Proline The catabolism of proline takes place in mitochodria. Since proline does not participate in transamination, the nitrogen of this imino acid is retained throughout its oxidation to 1‐ pyrolline‐5‐carboxylate, ring opening to glutamate‐‐ semialdehyde, and oxidation to glutamate, and is only removed during transamination of glutamate to ‐ketoglutarate. There are two metabolic disorders of proline catabolism. Both types are inherited as autosomal recessive traits, and are consistent with a normal adult life.
    [Show full text]
  • Microfilms International 300 N
    INFORMATION TO USERS This reproduction was made from a copy of a document sent to us for microfilming. While the most advanced technology has been used to photograph and reproduce this document, the quality of the reproduction is heavily dependent upon the quality of the material submitted. The following explanation of techniques is provided to help clarify markings or notations which may appear on this reproduction. I. The sign or "target" for pages apparently lacking from the document photographed is "Missing Pagets)". II' it was possible to obtain the missing pagers) or section, they are spliced into the film along with adjacent pages. This may have necessitated cu tting th rough an image and duplicating adjacent pages to assure complete continuity. 2. When an image on the film is obliterated with a round black mark. it is an indication of either blurred copy because of movement during exposure, duplicate copy, or copyrighted materials that should not have been filmed. For blurred pages, J good image of the page can be found in the adjacent frame. If copyrighted materials were deleted, a target note will appear listing the pages in the adjacent frame. 3. When a map, drawing or chart, ctc., is part of the material being photographed. a definite method of "sectioning" the material has been followed. It is customary to begin filming at the upper left hand corner of a large sheet and to continue from left to right in equal sections with small overlaps. If necessary, sectioning is continued again-beginning below the first row and continuing on until complete.
    [Show full text]
  • Care Coordination for California's
    Care Coordination for California’s Children and Youth with Special Health Care Needs: Building Blocks from other States PREPARED FOR THE LUCILE PACKARD FOUNDATION FOR CHILDREN’S HEALTH BY SHARON SILOW-CARROLL BROOKE EHRENPREIS STAN ROSENSTEIN JUNE 2014 Care Coordination for California’s Children and Youth with Special Health Care Needs: Building Blocks from other States June 2014 Contents Acknowledgements ....................................................................................................................................... 1 Introduction .................................................................................................................................................. 3 Care Coordination Approaches in Six Other States ...................................................................................... 6 Decision Points and Considerations for Building a Care Coordination Program .......................................... 7 Eligibility .................................................................................................................................................... 7 Eligibility Considerations for California ................................................................................................. 8 Care Coordination Services and Standards ............................................................................................... 9 Service/Standards Considerations for California ................................................................................ 11 Payment/Reimbursement
    [Show full text]